Background on Weight Loss Medications Under CMS For two decades, Medicare Part D has prohibited coverage of weight-loss drugs, largely because of legitimate safety concerns at the time (think fen-phen)
The 10 million times claim is almost certainly hype
Foam usually goes away on its own, but continuous foam means the tirzepatide powder is broken and needs to be thrown away
When combined with semaglutide, there is a slightly higher risk of blood sugar fluctuations
Logging how hungry you feel throughout the day, how much food satisfies you, and whether cravings have changed provides qualitative data about whether the peptide is working at a mechanistic level
In conclusion, Semaglutide is an effective medication for treating obesity and helping people achieve long-term weight loss goals when combined with lifestyle modifications such as diet and exercise